Novel Molecular Targets for Mood Disorders and Psychosis Proceedings of a Workshop (2021) / Chapter Skim
Currently Skimming:
1 Introduction and Background
1 Introduction and Background
Pages 1-4
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 1... ...
. Of particular concern, she said, is that anxiety, mood, impulse control, and substance abuse disorders start at younger ages than most other disorders and often persist throughout the lifespan, resulting in a lifetime of suffering for many individuals.
|
From page 2... ...
convened a workshop in March 2021 titled Novel Molecular Targets for Mood D isorders and Psychosis. WORKSHOP OBJECTIVES The goal of the workshop was to catalyze the development of new pharmacologic treatments for psychiatric disorders by reviewing the challenges and opportunities encountered during the development of recently approved drugs and applying the lessons learned to the exploration of novel molecular targets, said Brady (see Box 1-1)
|
From page 3... ...
• Explore what is known about use of these agents across the lifespan, including in adolescents and young adults. • Consider emerging molecular targets for treating psychosis and cogni tive impairment in schizophrenia, and how therapeutic development could be informed by lessons learned in developing novel therapeutics for mood disorders.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.